Evidence map›Paper›PMID 33910856›Full record

ArticleIn vivo (Athens, Greece)

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Reinhard E Friedrich, Jozef Zustin, Andreas M Luebke, Thorsten Rosenbaum, Martin Gosau, Christian Hagel, Felix K Kohlrusch, Ilse Wieland, Martin Zenker

Open access · diamondAbstract readCase Reports
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Reinhard E FriedrichOral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany; rfriedrich@uke.de.
Jozef ZustinInstitute of Osteology and Biomechanics, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Andreas M LuebkeInstitute of Pathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Thorsten RosenbaumDepartment of Pediatrics, Sana-Kliniken Duisburg, Duisburg, Germany.
Martin GosauOral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Christian HagelInstitute of Neuropathology, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Felix K KohlruschOral and Craniomaxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Hamburg, Germany.
Ilse WielandInstitute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Martin ZenkerInstitute of Human Genetics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Universität Hamburg · DEOtto-von-Guericke University Magdeburg · DESana Kliniken Duisburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimNeurofibromatosis type 1 (NF) is an autosomal dominant hereditary disease. The cardinal clinical findings include characteristic skeletal alterations. Difficulties in diagnosis and therapy can arise if an individual has further illnesses. CASE REPORT: This is a case report of a 16-year-old patient affected by NF1. She also suffered from Alagille syndrome and the consequences of fetal alcohol exposure. The patient's facial phenotype showed findings that could be assigned to one or more of the known diseases. The patient was referred for treating a cherubism-like recurrent central giant cell granuloma (CGCG) of the jaw. The patient developed bilateral, multilocular non-ossifying fibromas (NOF) of the long bones of the lower extremity. Treatment of the skeletal lesions consisted of local curettage. While NOF regressed after surgery, the CGCG of the jaw remained largely unchanged. Extensive genetic tests confirmed a previously unknown germline mutation in the JAG1 gene, the germline mutation of the NF1 gene, and the somatic mutation in the NF1 gene in the diffuse plexiform neurofibroma, but not in the CGCG.

conclusionAssigning facial findings to a defined syndrome is ambiguous in many cases and especially difficult in patients who have multiple diseases that can affect the facial phenotype. Surgical therapy should be adapted to the individual findings.

Indexed as

Alagille SyndromeCherubismNeurofibromatosis 1AdolescentFemaleHumansLower ExtremityPhenotypeAlagille syndromecentral giant cell granulomacentral giant cell lesioncherubismJaffe-Campanacci syndromeNeurofibromatosis type 1non-ossifying fibromaroot resorption

Identifiers

PMID33910856
PMCPMC8193341
OpenAlexW3159308293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.